aTyr Pharma Announces Second Quarter 2021 Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
aTyr Pharma (LIFE) Misses Q2 EPS by 13c
August 10, 2021 4:25 PM EDTaTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.64), $0.13 worse than the analyst estimate of ($0.51).
Cash, cash equivalents and investments as of June 30, 2021 were $44.1 million.
We recently completed the last subject visit in our Phase 1b/2a proof-of-concept study of our lead therapeutic candidate,... More
